✦ LIBER ✦

Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian Breast Group

✍ Scribed by L Hakamies-Blomqvist; M.-L Luoma; J Sjöström; A Pluzanska; M Sjödin; H Mouridsen; B Østenstad; I Mjaaland; S Ottosson-Lönn; J Bergh; P.-O Malmström; C Blomqvist

Book ID: 117656862
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 199 KB
Volume: 36
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(00)00126-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel compared with sequential metho

Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group

✍ J. Sjöström; C. Blomqvist; H. Mouridsen; A. Pluzanska; S. Ottosson-Lönn; N.-O. B 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views